JP2016513709A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513709A5
JP2016513709A5 JP2016502520A JP2016502520A JP2016513709A5 JP 2016513709 A5 JP2016513709 A5 JP 2016513709A5 JP 2016502520 A JP2016502520 A JP 2016502520A JP 2016502520 A JP2016502520 A JP 2016502520A JP 2016513709 A5 JP2016513709 A5 JP 2016513709A5
Authority
JP
Japan
Prior art keywords
formula
compound
chloro
phenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502520A
Other languages
English (en)
Japanese (ja)
Other versions
JP6340409B2 (ja
JP2016513709A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027694 external-priority patent/WO2014152752A1/en
Publication of JP2016513709A publication Critical patent/JP2016513709A/ja
Publication of JP2016513709A5 publication Critical patent/JP2016513709A5/ja
Application granted granted Critical
Publication of JP6340409B2 publication Critical patent/JP6340409B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502520A 2013-03-14 2014-03-14 キラルキヌレニン化合物の合成方法 Expired - Fee Related JP6340409B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785807P 2013-03-14 2013-03-14
US61/785,807 2013-03-14
PCT/US2014/027694 WO2014152752A1 (en) 2013-03-14 2014-03-14 Methods for the synthesis of chiral kynurenine compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018093249A Division JP6618569B2 (ja) 2013-03-14 2018-05-14 キラルキヌレニン化合物の合成方法

Publications (3)

Publication Number Publication Date
JP2016513709A JP2016513709A (ja) 2016-05-16
JP2016513709A5 true JP2016513709A5 (cg-RX-API-DMAC7.html) 2017-10-05
JP6340409B2 JP6340409B2 (ja) 2018-06-06

Family

ID=51581307

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502520A Expired - Fee Related JP6340409B2 (ja) 2013-03-14 2014-03-14 キラルキヌレニン化合物の合成方法
JP2018093249A Expired - Fee Related JP6618569B2 (ja) 2013-03-14 2018-05-14 キラルキヌレニン化合物の合成方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018093249A Expired - Fee Related JP6618569B2 (ja) 2013-03-14 2018-05-14 キラルキヌレニン化合物の合成方法

Country Status (6)

Country Link
US (2) US9834801B2 (cg-RX-API-DMAC7.html)
EP (1) EP2970097B1 (cg-RX-API-DMAC7.html)
JP (2) JP6340409B2 (cg-RX-API-DMAC7.html)
CN (2) CN105164100B (cg-RX-API-DMAC7.html)
CA (1) CA2941559A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014152752A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9834801B2 (en) 2013-03-14 2017-12-05 Vistagen Therapeutics, Inc. Methods for the synthesis of chiral kynurenine compounds
EA201792571A1 (ru) 2015-05-22 2018-06-29 Вистаджен Терапьютикс, Инк. Терапевтическое применение l-4-хлорокинуренина
EP3347346A1 (en) * 2015-09-08 2018-07-18 Cephalon, Inc. Prodrugs of chlorokynurenines
WO2018044724A1 (en) 2016-08-31 2018-03-08 Ampio Pharmaceuticals, Inc. Treatment of disease with n-acetyl kynurenine
WO2018180116A1 (ja) 2017-03-29 2018-10-04 富士フイルム株式会社 構造体および光センサ
US11427530B2 (en) 2018-02-09 2022-08-30 Vistagen Therapeutics, Inc. Synthesis of 4-chlorokynurenines and intermediates
CN113549661B (zh) * 2020-04-26 2022-08-30 赤壁生合元科技有限公司 生物催化合成L-4-Cl-犬尿氨酸或L-4-Br-犬尿氨酸的方法及应用
CN113549662B (zh) * 2020-04-26 2022-06-03 赤壁市高质量发展研究院有限公司 一种用MOF载酶技术高效制备抗抑郁药前药L-4-Cl-犬尿氨酸的方法及应用
CN119317838A (zh) 2022-06-30 2025-01-14 株式会社A-Clip研究所 检查血管炎的罹患状态或covid-19的重症化风险的方法、检查用试剂盒、伴随诊断试剂以及检查用标记物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766261A (en) 1970-08-21 1973-10-16 Us Agriculture Process of producing kynurenine
US3702255A (en) 1970-08-21 1972-11-07 Us Agriculture Kynurenine derivatives as sweetening agents
US3765261A (en) * 1973-01-02 1973-10-16 Hurst Performance Unitary stick transfer case shifter
US5519055A (en) 1993-08-06 1996-05-21 University Of Maryland At Baltimore Substituted kynurenines and process for their preparation
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
GB9522615D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
ITMI20041626A1 (it) 2004-08-06 2004-11-06 Roberto Pellicciari Inibitori della chinurenina-ammino-trasferasi
US7622495B2 (en) * 2006-10-03 2009-11-24 Neurim Pharmaceuticals (1991) Ltd. Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
WO2010067613A1 (ja) * 2008-12-11 2010-06-17 東洋紡績株式会社 L-サクシニルアミノアシラーゼ、およびこれを用いたl-アミノ酸の製造方法
US9834801B2 (en) 2013-03-14 2017-12-05 Vistagen Therapeutics, Inc. Methods for the synthesis of chiral kynurenine compounds

Similar Documents

Publication Publication Date Title
JP2016513709A5 (cg-RX-API-DMAC7.html)
JP2017122107A5 (cg-RX-API-DMAC7.html)
JP2010095546A5 (cg-RX-API-DMAC7.html)
JP2014221842A5 (cg-RX-API-DMAC7.html)
JP2017222697A5 (cg-RX-API-DMAC7.html)
JP2010174033A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
RU2015106856A (ru) Способ получения производных пиразолкарбоновой кислоты
JP2015535839A5 (cg-RX-API-DMAC7.html)
JP2015532645A5 (cg-RX-API-DMAC7.html)
MX352470B (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
BR112013019025A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluoro-6-(substituído) picolinatos
MX2018001145A (es) Métodos para la preparación de ácidos biliares y derivados de los mismos.
JP2016540774A5 (cg-RX-API-DMAC7.html)
JP2015199738A5 (cg-RX-API-DMAC7.html)
JP2020073474A5 (cg-RX-API-DMAC7.html)
MX373700B (es) Composicion acuosa novedosa.
RU2019119584A (ru) Способ получения триазолопиридинового соединения
EA201992771A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
WO2015068175A3 (en) An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
JP2018009003A5 (cg-RX-API-DMAC7.html)
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
JP2013241421A5 (cg-RX-API-DMAC7.html)
HRP20191632T1 (hr) Kemijski postupak dobivanja spiroindolona i njihovih međuprodukata
MX375839B (es) Proceso para la preparación de 1-(3,5-dicloro-4-fluorofenil)-2,2,2-trifluoroetanona.